Emad Shash: Excited to share my latest publication in JCO Precision Oncology
Emad Shash, General Manager of the Breast Cancer Comprehensive Center of the National Cancer Institute at Cairo University, shared on LinkedIn:
“Excited to share my latest publication in JCO Precision Oncology!
In this piece, I explore a topic close to my heart: the impact of chemotherapy-induced peripheral neuropathy (CIPN) on cancer survivors and how it increases their risk of falls. Our research highlights the potential of wearable tech to better track balance and gait issues, giving us more accurate insights compared to traditional self-reports.
However, the work also points to key areas for growth:
We need to involve more diverse patients across age, gender, and cancer types.
Gathering more reliable fall data—not just relying on memory—will improve our findings.
There’s a real need for specific rehab programs tailored to these impairments.
Finally, bringing wearable tech into daily practice won’t be easy, but with the right support, it’s possible.
This research is just one step, but I’m hopeful it can spark new ideas and improve the quality of life for cancer survivors. Thank you to everyone who supports this journey—let’s keep pushing forward!”
Author: Emad Shash
More posts featuring Emad Shash on oncodaily.com
Emad Shash is the General Manager of the Breast Cancer Comprehensive Center of the National Cancer Institute at Cairo University. He is also a Lecturer at Cairo University and Medical Oncologist at the National Cancer Institute.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023